MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Through Friday, with the latest quarterly results in from more than three-fifths of the S&P 500, 77% have turned in earnings per share higher than analysts expected, according to FactSet.

It's past the peak of earnings season and results have been largely favorable, with 60% of companies so far beating sales ...

CPI data, Powell’s remarks, and retail sales will shape market sentiment. Earnings from McDonald’s, Roku, and Coinbase add ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

It's the first quarter in many those tech companies haven't offered earnings surprises It's a sea of green this morning - congrats Eagles fans - with Wall Street also pointing to a higher start, led ...

DA Davidson increased their FY2025 earnings estimates for AZEK in a report issued on Wednesday, February 5th. DA Davidson analyst K. Yinger now forecasts that the company will post earnings of $1.31 ...

The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal second-quarter earnings report. CEO Max ...

But over the long haul, it's USA all the way, says our call of the day from Northern Trust Asset Management's chief investment officer of global asset allocation, Anwiti Bahuguna, who spoke to ...

Operator: And good day, and thank you for standing by. Welcome to the first quarter 2025 ESCO Technologies earnings ...

BorgWarner reported mixed results with earnings surpassing expectations, yet revenue slightly missed estimates due to sector challenges.